CAP organs can be propaged on multiwell plates making them ideal for conducting rapid screening of drug candidates. Since CAP organs are accurate assembleages they also express biomarkers as seen in vivo, therefore drug screening for specific biomarkers is improved over other available models. Of special value are disease models, where drugs can be shown to reverse or normalize cellular responses within target organs. The genetic and chemical means to create disease models are available, but what has been missing is the ability to assemble these cells back into organs. CAP organs solve the problem. Work with HOF Therapeutics to design the exact disease model needed. Our panel of organ models also provides advanced data on off-target effects in other organs. The companies taking advantage of the CAP organ improvement can now use these in drug screening protocols. Prior to expensive clinical trials, making full use of efficacy studies in CAP organs improves your ability to find the best drug.